Abstract: This paper reports the synthesis and characterization of eight series of 1-aryl-4-(2-aryl-1-diazenyl)-piperazines (12 to 19). Several series of these triazenes have been synthesized by the diazotization of a primary arylamine followed by diazonium coupling with a secondary arylpiperazine . The arylpiperazines used in this study are: 1-phenylpiperazine, 1-(4-fluorophenyl-)piperazine, 1-(4-chlorophenyl-)piperazine, 1-(3,4-dichlorophenyl-)piperazine, 1-(2-methylphenyl-)-piperazine, 1-(4-acetophenyl-)-piperazine, 1-(2-pyridyl-)piperazine and 2-cyanophenylpiperazine. These new triazenes (series 12-19) have been identified with a cocktail of contemporary spectroscopic techniques, notably infra-red and nuclear magnetic spectroscopy, supported by high resolution electron ionization mass spectrometry.
INTRODUCTION
The chemistry of triazenes has been explored since the latter part of the eighteenth century. Most of the work centered on the chemistry of the 1-aryl-3,3-dialkyltriazenes (1) and to a lesser extent on the chemistry of the monoalkyltriazenes (2). The field of investigation of anti-tumour triazenes was established in the 1950s with the discovery of the biological activity of DTIC, also known as Dacarbazine, 5-(3,3-dimethyltriazen-1-yl)imidazole-4-carboxamide (3) [1] and in the 1980s with the discovery of temozolomide, also known as Temodal, (3,4-dihydro-3-methyl-4-oxoimidazo 5,1-d -as-tetrazine-8-carboxamide) (4) [2] . The mechanism of action of these drugs is only partially understood, but researchers do agree that the effectiveness of triazene-based antitumour agents may be due to their ability to alkylate DNA. These drugs are still considered very effective therapies, especially Dacarbazine in the treatment of malignant melanomas [3] and Temodal for brain cancers [4] .
From an alternative perspective, the medicinal chemistry of piperazine derivatives has attracted considerable interest. Research on arylpiperazines (5) is quite extensive due to their biological applications. They are especially known for their high affinity toward serotonin receptors, chiefly 5-HT1A receptors. Many common anxiolytics (antianxiety agents) and antidepressants incorporate arylpiperazines [5] . It is believed that arylpiperazine derivatives act as 5-HT1A receptor antagonists [6] . The possibility of combining the structural unit of a triazene with that of a piperazine raises interesting questions regarding the biological activity that might be generated from such a combination.
Vaughan et al. recently explored and expanded the range of triazene derivatives of piperazines in a series of papers. The structures investigated use (1, x)-diazocycloalkanes (6) where m = 1 or 2 and n = 2, 3, 4, or 5, as the general structure. The specific structures varied the R moiety, the homology of the piperazine ring, or a combination of the two. In a previous report [7] , the 1-(2-aryl-1-diazenyl-) 4-methylpiperazines (7a) were prepared by reaction of 1-methylpiperazine with the appropriate diazonium salt; this work also reported the analogous synthesis of the Nethoxycarbonylpiperazines (7b). A subsequent study [8] of the diazonium coupling reaction with piperazine itself in 2 : 1 proportions resulted in the isolation and identification of the bis-triazene series (8). Some of the compounds in this series had been previously synthesized, but characterization had not been in depth [9] .
A further paper in Vaughan's series [10] studied the effects of different piperazine ring homology, specifically diazepanes (9 and 10). One possible direction for further study arising from these papers would involve the synthesis of a series of compounds maintaining the (1, x)-diazocycloalkane base structure (6) with the piperazine ring, while further adding to different functional groups on the R group. The R group has included alkylated and esterified substituents, as well as the aryldiazenyl group in bis-triazenes (8 -10). A logical next step would be to synthesize a series with the R group as an aryl moiety (11). This extension will further add to the information on similar series, and provide a synthetic method for future studies. Additional interest in these new compounds is derived from the potential medicinal applications of compounds of type 11.
In this paper, several novel compounds of a new series of triazenes (12-17) have been synthesized and characterized.
The series has also been extended to the triazene series (18 and 19).
All compounds have been purified and characterized by IR and NMR spectroscopy and high resolution mass spectrometry (EI).
EXPERIMENTAL
For details of the experimental methods such as IR, NMR, mass spectrometry, melting point measurement, etc., see any of the prior references of this author [7, 8, 10 ].
1-Aryl-4-(2-aryl-1-Diazenyl)-Piperazines (Series 12 to 19 Inclusive)

General Procedure
An aromatic primary amine (0.010 mol) was dissolved in 3M HCl (12.0 mL), and placed in an ice bath to cool to 0ºC. Sodium nitrite (0.011 mol), dissolved in water (3.0 mL) was added to the solution, and stirred for 0.5 hours. Concurrently, the appropriate aryl-piperazine (0.011 mol) was dissolved in water (1.0 mL), and cooled to 0ºC. If necessary to dissolve the alkylpiperazine, a small amount of 3M HCl (1.0 to 3.0 mL) was added. The piperazine solution was added slowly to the diazonium salt solution, and the resulting mixture was stirred for 0.5 hours. The solution was then neutralized with saturated sodium bicarbonate and left stirring in the cold for two hours. The product was collected using vacuum filtration if it was a solid and by extraction procedures if it was an oil. The solids were purified by recrystallization using an appropriate solvent. Oily products were isolated by extraction of the aqueous reaction mixture with dichloromethane, drying the organic layer over anhydrous magnesium sulphate, followed by evaporation of the solvent under vacuum.
RESULTS AND DISCUSSION
1-Aryl-4-(2-aryl-1-diazenyl)-piperazines: Synthesis 1-Aryl-4-(2-aryl-1-diazenyl)-piperazines (Series 12-17) were produced in good to excellent yields (20 -99%) by reaction of a diazonium salt with a specific N-arylpiperazine. Physical data and IR spectroscopic data of these compounds are listed in Tables 1-6 . The integrity of all compounds was verified by high-resolution mass spectrometry (EI) (see Tables 7-12 ). { See structures in the Introduction section above.} The 1-(2-pyridyl)-4-(2-aryl-1-diazenyl-)piperazines (series 18) were prepared by diazotization of the arylamine and coupling with 1-(2-pyridyl-)piperazine. The 1-(2-cyanophenyl)-4-(2-aryl-1-diazenyl-)piperazines (series 19) were prepared by diazotization of the aryl amine and coupling with 1-(2-cyanophenyl-)piperazine. Physical data and infrared frequencies of the compounds of 18 and 19 are provided in Tables 13 and 15 . Mass spectrometric data on these compounds are given in Tables 14 and 16. 
Infrared Spectral Analysis
All compounds in series 12 -19 were characterized by IR spectroscopy in order to confirm the presence of the appropriate aryl substituents and to confirm the expected substitution pattern of the aryl rings with reference to the OOP bending vibrations of aromatic-Hgroups C. All of the compounds in series 12 show out-of-plane (OOP) bending vibrations of the substituted benzene ring. The compounds of other series display analogous IR bands. Aliphatic and aromatic carbon-hydrogen stretches are not reported because the nujol peaks overwhelm the peaks of interest. In the case of the oil (12i), for which the IR spectrum was collected as a neat liquid, aliphatic carbon-hydrogen peaks were found at 2820 and 2976 cm -1 , and an aromatic carbon-hydrogen peak was found at 3064 cm -1 .
Significantly, it should be noted here that the analysis of the compounds of series 12 with the strongly electronwithdrawing substituent, p-nitro-, p-cyano-and p-methoxycarbonyl-, namely compounds 12h, 12a and 12b, is not included in this paper. The reason for this omission is that the products of these reactions are not pure and we believe that the formation of these triazenes is accompanied by the formation of isomeric azo-compounds. The formation of azo-compounds is only observed in the case of these three compounds. All other compounds of series 12 behave "normally" and afford single compounds characterized as the triazenes shown. Furthermore, the compounds of series 13 -19 behave "normally" and do not give rise to isomeric azo compounds. The evidence that corroborates the azo compound hypothesis is somewhat involved, requiring the synthesis and characterization of model azo compounds. These results will be described in full detail in a follow-up paper to this one.
H NMR Spectral Analysis of Series 12 to 19
The proton nuclear magnetic resonance data of the members of series 12 to 19 is listed in Tables 17-24 . These results provided unequivocal structural information for the new triazenes of series 12 to 19. Fig. (1) shows the labeling of the piperazine-ring protons described in the analysis information found in the Tables 17-24. The aromatic resonance signals of the para-disubstituted compounds (12c-g) displayed the expected multiplicity of an AA'BB' system. The piperazine resonance signals (12c -g and 12i) displayed the expected multiplicity of an A 2 B 2 system. The 4-fluorophenyl ring resonance signals (13a -c) displayed a complicated splitting pattern. The signals were consistent within the series, and were found as a multiplet in the range δ6.96 -7.04. This complicated pattern is due to the NMR activity of fluorine. The protons of the tolyl methyl substituent (13c) had δ2 a.39 singlet. The signal full NMR at information for series (13) can be found in Table 18 . Table 19 . 1 H NMR spectral analysis of the 1-(3,4-dichlorophenyl)-4-(2-aryl-1-diazenyl)-piperazines (series 15) provided unequivocal structural information for these triazenes. The NMR analysis information can be found in Table  20 , and the proton labeling is shown in Fig. (2) . its large coupling constant corresponds to vicinal coupling with H e . Its doublet of doublet signals resonates in the range δ 6.78 -6.81. H e was assigned its position because of its doublet and large coupling constant which matches H d . Its doublet signals resonate between δ 7.01 -7.03.
The piperazine resonance signals (15a -h) also displayed the expected multiplicity of an A 2 B 2 system. The triplet signals were found between δ 3.33 -4.07. The O-methyl group of the alkoxy substituent (15d) appears as a singlet atδ 3.82. The methyl protons that were part of the acetyl group (15b) appear as a singlet at δ 2.60. The tolyl methyl substituent (15f) had a singlet signal at δ 2.39. Table 21 shows the details of the 1 H NMR analysis of the 1-(ortho-tolyl)-4-(2-aryl-1-diazenyl)-piperazines 16a-f. The piperazine resonance signals (16a -g) displayed the multiplicity of an A 2 B 2 system. The triplet signals were found between δ3.08 -4.46.
1 H NMR spectral analysis of the 1-(4-Acetophenyl)-4-(2-aryl-1-diazenyl)-piperazines (17 a-c) (Fig. 1) gave very similar results which are detailed in Table 22 . 
